CULLINAN THERAPEUTICS, INC. (CGEM) Operating income 2020–2025
CULLINAN THERAPEUTICS, INC. (CGEM) annual operating income history from SEC filings — each fiscal year as reported.
-$241.6MFY2025 · since FY2020: -$60.3M → -$241.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$241.6M | -22.7% |
| FY2024 | -$196.9M | -3.1% |
| FY2023 | -$191.1M | -232.1% |
| FY2022 | $144.6M | +312.9% |
| FY2021 | -$68.0M | -12.6% |
| FY2020 | -$60.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice